BONE MARROW RETICULIN FIBROSIS AS A PROGNOSTIC MARKER IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS TREATED IN THE ERA OF NOVEL AGENTS

被引：0
|
作者：
Suriu, C. [1 ,2 ]
Livne, M. [2 ]
Sonkin, V. [1 ]
Akria, L. [1 ,2 ]
Barhoum, M. [1 ]
Braester, A. [1 ,2 ]
机构：
[1] Galilee Med Ctr, Nahariyya, Israel
[2] Bar Ilan Univ, Fac Med Galilee, Safed, Israel
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1976
引用
收藏
页码：793 / 793
页数：1
相关论文
共 50 条
  • [41] Improving time to initiation of bone modifying agents in patients with newly diagnosed multiple myeloma.
    Rosko, Nathaniel
    Lee, Sarah
    Samaras, Christy Joy
    Mejia, Alex V.
    Anwer, Faiz
    Faiman, Beth
    Mathur, Saveta
    Hamilton, Kimberly
    Reed, Janice
    Karam, Mary Ann
    Valent, Jason Neil
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [42] Improving time to start bone modifying agents in newly diagnosed multiple myeloma patients.
    Lee, Sarah
    Rosko, Nathaniel
    Reed, Janice
    Karam, Mary Ann
    Faiman, Beth
    Mathur, Saveta
    Hamilton, Kimberly
    Mejia, Alex V.
    Anwer, Faiz
    Samaras, Christy Joy
    Valent, Jason Neil
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (27)
  • [43] Asymptomatic Amyloidosis at the Time of Diagnostic Bone Marrow Biopsy in Newly Diagnosed Patients with Multiple Myeloma and Smoldering Multiple Myeloma.
    Siragusa, Sergio
    Morice, William
    Gertz, Morie A.
    Kyle, Robert
    Greipp, Philip R.
    Lust, John A.
    Witzig, Thomas E.
    Lacy, Martha Q.
    Zeldenrust, Steven R.
    Rajkumar, S. Vincent
    Hayman, Suzanne R.
    Buadi, Francis
    Russell, Stephen J.
    Kumar, Shaji
    Dingli, David
    Dispenzieri, Angela
    BLOOD, 2009, 114 (22) : 1096 - 1096
  • [44] Prognostic significance of t(11;14) expression by FISH in patients with newly diagnosed multiple myeloma in the era of novel therapies.
    Velez, Miguel Gonzalez
    Parrondo, Ricardo Daniel
    Andrews, Tracy
    Duma, Narjust
    Richter, Joshua Ryan
    Vesole, David H.
    Siegel, David Samuel DiCapua
    Biran, Noa
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [45] Prognostic Impact of T(11;14) in Newly Diagnosed Patients with Multiple Myeloma in the Era of Modern Treatments
    Ntanasis-Stathopoulos, Loannis
    Terpos, Evangelos
    Malandrakis, Panagiotis
    Briasoulis, Alexandros
    Filippatos, Charalampos
    Fotiou, Despina
    Migkou, Magdalini
    Spiliopoulou, Uasiliki
    Theodorakakou, Foteini
    Kanellias, Nikolaos
    Eleutherakis-Papaiakovou, Evangelos
    Kastritis, Efstathios
    Dimopoulos, Meletios-Athanasios
    Gavriatopoulou, Maria
    BLOOD, 2024, 144 : 6968 - 6969
  • [46] Stromal Cell-Activated Bone Marrow Neutrophils Provide BAFF in Newly Diagnosed and Treated Multiple Myeloma
    de Jong, Madelon M. E.
    Fokkema, Cathelijne
    Papazian, Natalie
    van Heusden, Teddie
    Vermeulen, Michael
    Tahri, Sabrin
    Hoogenboezem, Remco
    van Duin, Mark
    van de Woestijne, Pieter
    Langerak, Anton
    Broijl, Annemiek
    Sonneveld, Pieter
    Cupedo, Tom
    BLOOD, 2022, 140 : 4181 - 4182
  • [47] Increased cytotoxic T-cell infiltrates in the bone marrow is an independent adverse prognostic factor in patients with newly diagnosed multiple myeloma
    Nowakowski, Grzegorz S.
    Li, Chin-Yang
    Dingli, David
    Kumar, Shaji
    Gertz, Morie A.
    Lacy, Martha Q.
    Last, John A.
    Dispenzieri, Angela
    Greipp, Philip R.
    Zeldenrust, Steven
    Buadi, Francis
    Hayman, Suzanne
    Kyle, Robert A.
    Rajkumar, Vincent S.
    BLOOD, 2007, 110 (11) : 446A - 447A
  • [48] The Impact of Induction Regimen Choice on Transplant Outcome and Survival in Newly Diagnosed Multiple Myeloma in the Era of Novel Agents
    Chakraborty, Rajshekhar
    Kumar, Shaji
    Buadi, Francis
    Dingli, David
    Dispenzieri, Angela
    Hayman, Suzanne R.
    Hogan, William J.
    Kapoor, Prashant
    Lacy, Martha Q.
    Leung, Nelson
    Gertz, Morie A.
    BLOOD, 2015, 126 (23)
  • [49] The role of novel agents on the reversibility of renal impairment in newly diagnosed symptomatic patients with multiple myeloma
    M A Dimopoulos
    M Roussou
    M Gkotzamanidou
    N Nikitas
    E Psimenou
    D Mparmparoussi
    C Matsouka
    M Spyropoulou-Vlachou
    E Terpos
    E Kastritis
    Leukemia, 2013, 27 : 423 - 429
  • [50] The role of novel agents on the reversibility of renal impairment in newly diagnosed symptomatic patients with multiple myeloma
    Dimopoulos, M. A.
    Roussou, M.
    Gkotzamanidou, M.
    Nikitas, N.
    Psimenou, E.
    Mparmparoussi, D.
    Matsouka, C.
    Spyropoulou-Vlachou, M.
    Terpos, E.
    Kastritis, E.
    LEUKEMIA, 2013, 27 (02) : 423 - 429
12345